Does CETUXIMAB Cause Squamous cell carcinoma? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Squamous cell carcinoma have been filed in association with CETUXIMAB (ERBITUX). This represents 0.1% of all adverse event reports for CETUXIMAB.
14
Reports of Squamous cell carcinoma with CETUXIMAB
0.1%
of all CETUXIMAB reports
4
Deaths
4
Hospitalizations
How Dangerous Is Squamous cell carcinoma From CETUXIMAB?
Of the 14 reports, 4 (28.6%) resulted in death, 4 (28.6%) required hospitalization.
Is Squamous cell carcinoma Listed in the Official Label?
Yes, Squamous cell carcinoma is listed as a known adverse reaction in the official FDA drug label for CETUXIMAB.
What Other Side Effects Does CETUXIMAB Cause?
Off label use (1,549)
Rash (883)
Diarrhoea (874)
Neutropenia (744)
Nausea (663)
Malignant neoplasm progression (662)
Dyspnoea (542)
Decreased appetite (541)
Vomiting (533)
Death (518)
What Other Drugs Cause Squamous cell carcinoma?
ADALIMUMAB (456)
RUXOLITINIB (413)
TACROLIMUS (327)
INFLIXIMAB (313)
RITUXIMAB (313)
LENALIDOMIDE (304)
PREDNISONE (267)
RANITIDINE (260)
CYCLOSPORINE (254)
METHOTREXATE (252)
Which CETUXIMAB Alternatives Have Lower Squamous cell carcinoma Risk?
CETUXIMAB vs CETYLPYRIDINIUM
CETUXIMAB vs CEVIMELINE
CETUXIMAB vs CHAMPIX
CETUXIMAB vs CHANTIX
CETUXIMAB vs CHENODIOL